Labcorp Acquires MLM to Expand Global Clinical Trial Labs
Burlington, North Carolina, USA, September 8, 2026 Labcorp has acquired MLM Medical Labs, strengthening its global central laboratory and...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Burlington, North Carolina, USA, September 8, 2026 Labcorp has acquired MLM Medical Labs, strengthening its global central laboratory and...
United States | December 23, 2025 — Fulgent Genetics has entered into a definitive agreement to acquire specific assets...
